Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03372434 · ClinicalTrials.gov registry record · NA
Clinical Investigation of the Next-Generation Intraocular Lenses
A NA study of Cataract, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 12
- Study locations
NCT03372434 is a NA study of Cataract that has completed, run by Abbott Medical Optics. The registered enrollment target is 225 participants, roughly in line with the 226-participant average among 83 other Cataract trials with a reported enrollment target. The trial reports 12 study locations across 8 states.
The verdict
NCT03372434, a NA study of Cataract, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 12
- Study locations
Study Summary
This study is a 6-month, prospective, multicenter, subject/evaluator-masked, bilateral, randomized clinical investigation of the TECNIS Next-Generation Model ZFR00 and Model ZYR00 IOLs versus the TECNIS Multifocal Model ZLB00 control IOL. The study will be conducted at up to 14 sites in the U.S.A and will enroll up to 260 subjects to achieve approximately 220 randomized and bilaterally-implanted subjects, resulting in approximately 195 evaluable subjects (65 in each test group and 65 in the control group) at 1 and 6 months. Subjects are to be implanted with the same IOL in both eyes, the ZFR00 IOL, the ZYR00 IOL or the ZLB00 control IOL. The eye implanted first will be considered the primary study eye.
Conditions Studied
Interventions
- DEVICE Investigational Intraocular Lens Device #1: Model ZFR00
- DEVICE Investigational Intraocular Lens Device #1: Model ZYR00
- DEVICE TECNIS Multifocal Intraocular Lens: Model ZLB00
Study Locations (12)
Texas
- Texas Eye and Laser Center - Hurst
- Lehmann Eye Center - Nacogdoches
- Focal Point Vision - San Antonio
Maryland
- Chesapeake Eye Care & Laser Center - Annapolis
- Eye Doctors of Washington - Chevy Chase
Tennessee
- Loden Vision Centers - Goodlettsville
- Eye Specialty Group - Memphis
California
- Empire Eye & Laser Center - Bakersfield
Florida
- Katzen Eye Care and Laser Center - Boynton Beach
Pennsylvania
- Scott & Christie and Associates, PC - Cranberry Township
South Carolina
- Carolina EyeCare Physicians, LLC - Mt. Pleasant
Washington
- Clarus Eye Centre - Lacey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2018-01-16 |
| Est. Completion | 2018-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03372434
The ClinicalTrials.gov registry entry for NCT03372434 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 226-participant average among 83 other Cataract trials with a reported enrollment target. The listed sponsor is Abbott Medical Optics, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 3 interventions - of which Investigational Intraocular Lens Device #1: Model ZFR00 is the first listed.
NCT03372434 reports 12 study locations spanning 8 distinct geographic areas - top geographies include Texas, Maryland, Tennessee.
Frequently Asked Questions
What is clinical trial NCT03372434 about?
NCT03372434 is a clinical study titled "Clinical Investigation of the Next-Generation Intraocular Lenses". This study is a 6-month, prospective, multicenter, subject/evaluator-masked, bilateral, randomized clinical investigation of the TECNIS Next-Generation Model ZFR00 and Model ZYR00 IOLs versus the TECNIS Multifocal Model ZLB00 control IOL. The study will be conducted at up to 14 sites in the U.S.A a...
What is the current status of trial NCT03372434?
This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2018-01-16. Estimated completion is 2018-10-30.
What conditions does trial NCT03372434 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT03372434?
The interventions under investigation include: Investigational Intraocular Lens Device #1: Model ZFR00 (DEVICE), Investigational Intraocular Lens Device #1: Model ZYR00 (DEVICE), TECNIS Multifocal Intraocular Lens: Model ZLB00 (DEVICE).
Who is sponsoring clinical trial NCT03372434?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03372434 being conducted?
This trial has 12 study locations across California, Florida, Maryland, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
Quatera 700 vs. Centurion
ACTIVE NOT RECRUITING · NA
-
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.